Real-time enrollment status for this clostridioides difficile infection recurrence clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 5:46 AM UTC
| NCT Number | NCT07250724 |
| Recruiting Status | Recruiting |
| Condition | Clostridioides Difficile Infection Recurrence |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Bactolife A/S |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of September 2, 2026: Clinical trial NCT07250724 is currently recruiting participants. This clinical trial study for clostridioides difficile infection recurrence is actively seeking new participants at 4 locations across the United States. The study is sponsored by Bactolife A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07250724 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07250724 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.